SHIRE HUMAN GENETIC THERAPIES, INC.
Patent Owner
Stats
- 66 US PATENTS IN FORCE
- 18 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 66 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,036 Total Citation Count
- Apr 20, 1994 Earliest Filing
- 44 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,212 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE AAug 23, 17Mar 15, 18[A61K]
2018/0036,386 METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIAJul 12, 17Feb 08, 18[A61K]
2017/0267,986 GENERATION OF MANNOSE-6-PHOSPHATE CONTAINING RECOMBINANT ALPHA-N-ACETYL GLUCOSAMINIDASEJun 25, 15Sep 21, 17[A61K, C12N]
2017/0232,076 MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMESAug 11, 15Aug 17, 17[A61K, C12N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9814764 Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseMay 10, 13Nov 14, 17[A61K, C12N, C07K]
9694057 Stabilized compositions of proteins having a free thiol moietyJun 18, 15Jul 04, 17[A61K, C12N, B65B]
9682129 Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfataseDec 21, 12Jun 20, 17[A61K, C12N]
9623090 Compositions and methods for treating type III gaucher diseaseMar 01, 13Apr 18, 17[A61K, G01N]
9597376 Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisAug 19, 15Mar 21, 17[A61K]
9567585 Antisense oligonucleotide modulators of serotonin receptor 2C and uses thereofNov 09, 12Feb 14, 17[C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0202,929 LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITISAbandonedJan 20, 17Jul 20, 17[A61K, C12N]
2017/0004,827 Data Collection and Reporting System and MethodAbandonedJun 30, 15Jan 05, 17[G10L, G06F]
2016/0030,416 METHODS OF TREATING B2-BRADYKININ RECEPTOR MEDIATED ANGIOEDEMAAbandonedMar 12, 14Feb 04, 16[A61K]
2015/0313,971 METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIAAbandonedDec 06, 13Nov 05, 15[A61K]
2014/0057,296 ASSAYS FOR ANTIBODIES WHICH BIND TO THERAPEUTIC AGENTSAbandonedMar 01, 12Feb 27, 14[G01N]
2014/0037,612 SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE AAbandonedMay 24, 13Feb 06, 14[A61K]
2014/0004,097 METHOD OF PRODUCING RECOMBINANT IDURONATE-2-SULFATASEAbandonedMar 14, 13Jan 02, 14[C12N]
2013/0337,482 ASSAYS AND KITS TO DETERMINE GALACTOCEREBROSIDASE ACTIVITY ON SOLID SUPPORTAbandonedOct 28, 11Dec 19, 13[C12Q]
2013/0295,071 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASEAbandonedApr 12, 13Nov 07, 13[A61K]
2013/0121,984 BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOFAbandonedNov 07, 12May 16, 13[A61K, C12Q]
2013/0028,881 DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIESAbandonedJun 20, 12Jan 31, 13[A61K, C12P, C12N, A61P]
2011/0318,324 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASEAbandonedJun 25, 11Dec 29, 11[A61K, A61P]
2011/0318,327 TREATMENT OF SANFILIPPO SYNDROME TYPE BAbandonedJun 25, 11Dec 29, 11[A61K, C12N, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
